“…Cellular mRNAs are subjected to multiple checkpoints, co‐ and post‐transcriptionally, before entering the cytoplasm and engaging in protein synthesis (as previously reviewed by Hilleren & Parker, 1999; Karamyshev & Karamysheva, 2018; Keene, 2007; Peck et al, 2019; Rougemaille et al, 2008; Tutucci & Stutz, 2011; Wolin & Maquat, 2019). As a result of these primary quality control checkpoints, mRNAs with serious aberrations, such as the lack of 5′ cap or the poly‐A tail, are retained and degraded within the nucleus through nuclear mRNA surveillance mechanisms (Klama et al, 2022; Singh et al, 2018; Stutz, 2003). Additionally, cells have co‐translational quality control mechanisms to detect mRNAs bearing subtle defective sequences, such as the insertion of or mutation of a stop codon (Bengtson & Joazeiro, 2010; Choe et al, 2016; Dimitrova et al, 2009; Powers et al, 2020; Shoemaker & Green, 2012).…”